Frontiers in Cellular and Infection Microbiology (Jul 2023)

Alteration and clinical potential in gut microbiota in patients with cerebral small vessel disease

  • Yachen Shi,
  • Yachen Shi,
  • En Zhao,
  • Lei Li,
  • Lei Li,
  • Songyun Zhao,
  • Haixia Mao,
  • Jingyu Deng,
  • Jingyu Deng,
  • Wei Ji,
  • Wei Ji,
  • Yang Li,
  • Yang Li,
  • Qianqian Gao,
  • Siyuan Zeng,
  • Lin Ma,
  • Guangjun Xi,
  • Guangjun Xi,
  • Yiping You,
  • Yiping You,
  • Junfei Shao,
  • Xiangming Fang,
  • Feng Wang,
  • Feng Wang

DOI
https://doi.org/10.3389/fcimb.2023.1231541
Journal volume & issue
Vol. 13

Abstract

Read online

BackgroundCerebral small vessel disease (CSVD) is a cluster of microvascular disorders with unclear pathological mechanisms. The microbiota-gut-brain axis is an essential regulatory mechanism between gut microbes and their host. Therefore, the compositional and functional gut microbiota alterations lead to cerebrovascular disease pathogenesis. The current study aims to determine the alteration and clinical value of the gut microbiota in CSVD patients.MethodsSixty-four CSVD patients and 18 matched healthy controls (HCs) were included in our study. All the participants underwent neuropsychological tests, and the multi-modal magnetic resonance imaging depicted the changes in brain structure and function. Plasma samples were collected, and the fecal samples were analyzed with 16S rRNA gene sequencing.ResultsBased on the alpha diversity analysis, the CSVD group had significantly decreased Shannon and enhanced Simpson compared to the HC group. At the genus level, there was a significant increase in the relative abundances of Parasutterella, Anaeroglobus, Megasphaera, Akkermansia, Collinsella, and Veillonella in the CSVD group. Moreover, these genera with significant differences in CSVD patients revealed significant correlations with cognitive assessments, plasma levels of the blood-brain barrier-/inflammation-related indexes, and structural/functional magnetic resonance imaging changes. Functional prediction demonstrated that lipoic acid metabolism was significantly higher in CSVD patients than HCs. Additionally, a composite biomarker depending on six gut microbiota at the genus level displayed an area under the curve of 0.834 to distinguish CSVD patients from HCs using the least absolute shrinkage and selection operator (LASSO) algorithm.ConclusionThe evident changes in gut microbiota composition in CSVD patients were correlated with clinical features and pathological changes of CSVD. Combining these gut microbiota using the LASSO algorithm helped identify CSVD accurately.

Keywords